Yu-jiao Zhou
Ministry Of Education Key Laboratory Of Child Development And Disorders, Chongqing Key Laboratory Of Child Rare Diseases In Infection And Immunity, No.20 Jinyu Road, Chongqing
Yubei, 401122, China
Yubei, 401122, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 14, 2024
RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 19, 2023
Case report: A case of severe acute hepatitis of unknown origin.
Journal: Frontiers in pediatrics
Published: June 22, 2022
Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity.
Journal: Frontiers in pharmacology
Published: December 16, 2021
SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters.
Journal: Frontiers in microbiology
Published: December 15, 2021
KAT2A Promotes Hepatitis B Virus Transcription and Replication Through Epigenetic Regulation of cccDNA Minichromosome.
Journal: Frontiers in microbiology
Published: October 15, 2021
DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis.
Journal: Hepatology (Baltimore, Md.)
Published: February 26, 2021
LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor.
Journal: Clinical science (London, England : 1979)
Published: July 24, 2020
Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim.
Journal: Journal of ethnopharmacology
Published: January 06, 2020
Overexpression of ubiquitin-conjugating enzyme E2 L3 in hepatocellular carcinoma potentiates apoptosis evasion by inhibiting the GSK3β/p65 pathway.
Journal: Cancer letters
Published: November 21, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026